[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

New Drug Delivery Market Study: Trying Out Nanotechnology for Novel Technologies and Approaches

27 Jan 2011 • by Natalie Aster

London – “The nano-enabled drug delivery market has seen high growth and is expected to grow at a faster rate in the near future. The market will witness increased competition, high investment from venture capitalists and governments. The M&A and licensing landscape will see significant changes in the future because the market is expected to become more lucrative.”

The report “Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential ” by GBI Research provides key data, information and analysis of the major trends and issues in Nanotechnology in Drug Delivery market. It provides a comprehensive insight into the role of Nanotechnology in Drug Delivery. The report also provides a detailed analysis of market characterization of nanotechnology in drug delivery market in terms of its market size, segmentation by key geography types and the major market drivers and barriers. The report talks about the technological trends over the years in use of nanotechnology in drug delivery.

Report Details:

Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential

Published: December 2010
Pages: 77
Price: US$ 3,500.00 US$ 2,975.00
Offer valid until January 31, 2011!

Key features of the report:

  • Complete trends analysis with special emphasis on its effects on the market;
  • Analysis of the key drivers and barriers that impact the global nanotechnology in drug delivery market;
  • Key regulations and acts that affect the global nanotechnology in drug delivery market.

Key benefits of the report:

  • Analysis of future players which are involved in nano-enabled drug development;
  • Study of major deals and partnerships between pharmaceutical industries;
  • Analysis of future opportunities and unmet needs for the nano-enabled drug delivery market.

According to a study conducted by Willi Paul, and Chandra P. Sharma, the nano-enabled drug delivery market was $1.7 billion in 2009 and expected to reach over $4.8 billion in 2012. The nano-enabled drug delivery market has plenty of opportunities and a high level of unmet need. Opportunities for creating a new drug delivery company are tremendous. Many small companies have launched the technology to develop novel methods for exploiting nanotechnologies in drug delivery. In the past, companies have been dedicated to the nano-enabled drug delivery that has been appearing all over the world. The creation of new companies will not only increase the investment and market growth, but also increase the competition in the market place. In addition, the emergence of new companies will provide licensing and merger and acquisition (M&A) opportunities for larger pharmaceutical markets.

More information can be found in the report “Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential ” by GBI Research .

To order the report or ask for sample pages contact [email protected]

Contacts

MarketPublishers, Ltd.
Mrs. Alla Martin
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]
MarketPublishers.com

Analytics & News

Weekly Digest